T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,065.00
-135.00 (-6.14%)
Oct 12, 2026, 3:30 PM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 98.42 billion as of October 9, 2026. It is the 27,475th most valuable company in the world and the 1,322nd biggest in South Korea. Its market cap has increased by 114.95% in one year.
Market Cap
98.42B
Enterprise Value
122.82B
Revenue
32.73B
Global Rank
Country Rank
#1,322 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 28, 2018, T&R Biofab's market cap has decreased from 101.48B to 98.42B, a decrease of -3.01%. That is a compound annual growth rate of -0.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 98.42B | -45.10% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boditech Med | 212.52B |
| Dongbang Medical | 131.88B |
| Shinhung | 131.57B |
| Osang Healthcare Co.,Ltd | 88.89B |
| Access Bio | 78.79B |
| Ray Co., Ltd. | 69.99B |
| Sugentech | 69.49B |
| P&S Robotics | 67.28B |